Virtual for Care Atrial Fibrillation Patients Using VIRTUES
1 other identifier
interventional
300
1 country
3
Brief Summary
Patients will atrial fibrillation, a type of irregular heart rhythm, frequently go to the emergency room in order to manage their condition. This study will use a chart review to look at the characteristics and frequency of atrial fibrillation patients who go to the emergency room. In addition to the chart review, patients with atrial fibrillation who have recently gone to the emergency room or have been hospitalized will be approached and asked if they want to use an electronic health care system that can be accessed by both themselves and their health care providers. Along with the system, patients will be given a Health Canada approved heart rhythm sensor, so patients will be able to record their heart rhythm when they feel symptoms and send the information to the heart rhythm team. The heart rhythm team will then make real-time recommendations to the patient about how they can manage their rhythm and symptoms. Patients will be asked to complete satisfaction and quality of life surveys. Our goal is to provide efficient and effective care for patients with AF, resulting in decreased repeat ED visits.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable atrial-fibrillation
Started Nov 2020
Typical duration for not_applicable atrial-fibrillation
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 2, 2020
CompletedFirst Posted
Study publicly available on registry
October 22, 2020
CompletedStudy Start
First participant enrolled
November 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2024
CompletedOctober 22, 2020
October 1, 2020
3 years
October 2, 2020
October 21, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of patients who present to the emergency department due to atrial fibrillation, after their index visit
See title
12 months
Secondary Outcomes (6)
Number of AF-related ER visit per patient, post index visit
12 months
Utility of the system
12 months
Survey-based experience with the VIRTUES application
Baseline, 3 months, 12 months
Pre and post patient reported outcomes using the Atrial Fibrillation Effect on Quality of Life (AFEQT) Questionnaire and the EQ-5D-5L
Baseline, 3 months, 12 months
Time to stroke/TIA, systematic embolism, cardiovascular (CV) hospitalization, death
12 months
- +1 more secondary outcomes
Study Arms (1)
VIRTUES Arm
EXPERIMENTALPatients in the VIRTUES arm will be offered enrollment into the virtual atrial fibrillation care platform.
Interventions
VIRTUES is a digital health platform that offers 2 way communication between clinicians and patients to address symptoms stemming from atrial fibrillation.
Eligibility Criteria
You may qualify if:
- able to provide informed consent
- documented symptomatic new-onset or pre-existing, non-valvular AF
- ER visit or hospitalization for primary AF in the last 6 months
- proficient in the English language
You may not qualify if:
- unable to provide informed consent
- planning to move/relocate during the period of study
- current pregnancy
- patient is a prisoner/incarcerated
- no access to a smart device with Bluetooth capabilities
- planned percutaneous coronary intervention, coronary artery bypass graphing or heart valve surgery within the next year
- any medical condition making 1 year survival unlikely
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Queen Elizabeth II Health Sciences Centre
Halifax, Nova Scotia, B3H 2Y9, Canada
Rachel Caris
London, Ontario, N6A 5A5, Canada
Sunnybrook Health Sciences Centre
Toronto, Ontario, M4N 3M5, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Allan C Skanes, Md
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Electrophysiology Laboratory
Study Record Dates
First Submitted
October 2, 2020
First Posted
October 22, 2020
Study Start
November 1, 2020
Primary Completion
November 1, 2023
Study Completion
November 1, 2024
Last Updated
October 22, 2020
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will not share